Deltex Medical will be supporting a forthcoming congress in London on May 28th. Current Initiatives, Research and the Role of Hemodynamic Monitoring is free to attend for clinicians and healthcare providers who are interested in the principles and latest evidence relating to Goal-Directed Hemodynamic Therapy (GDHT). Speakers at the event will include UCL Professors Monty Mythen and Mervyn Singer, both leading experts in their respective fields.
The timing is particularly appropriate, given the recent publication of the landmark FEDORA study that has demonstrated the positive effect of using ODM technology to guide fluid and vasoactive drug interventions.
The event will take place at the Great Russell Suite, Montague Hotel, London, WC1B 5BJ
